Crossmark

RETRACTED ARTICLE: Chemerin reverses neurological impairments and ameliorates neuronal apoptosis through ChemR23/CAMKK2/AMPK pathway in neonatal hypoxic–ischemic encephalopathy

Crossref DOI link: https://doi.org/10.1038/s41419-019-1374-y

Published Online: 2019-02-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Yixin

Xu, Ningbo https://orcid.org/0000-0001-9055-3597
Ding, Yan

Doycheva, Desislava Met

Zhang, Yiting

Li, Qian

Flores, Jerry

Haghighiabyaneh, Mina

Tang, Jiping

Zhang, John H. https://orcid.org/0000-0002-4319-4285
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01-NS104083)
License Information

Text and Data Mining valid from 2019-02-04

Version of Record valid from 2019-02-04
More Information

Article History

Received: 12 May 2018

Revised: 12 December 2018

Accepted: 7 January 2019

First Online: 4 February 2019

Change Date: 28 October 2025

Change Type: Correction

Change Details: This article has been retracted. Please see the Retraction Notice for more detail:

Change Details: https://doi.org/10.1038/s41419-025-08183-x

Conflict of interest

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below